surmount trials tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial SURPASS to SURMOUNT: The Tirzepatide
Pay in 4 interest-free payments of $7.11 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31



















:format(jpg)/d2lnr5mha7bycj.cloudfront.net/product-image/file/large_2b615cf4-8306-4850-861f-f805132f608e.png)





